Delta-Fly Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.2%.

Top 15 shareholders own 35.12% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.59%	Kiyoshi Eshima	707,000	JP¥522.5m	0%	no data
5.23%	Nippon Chemiphar Co., Ltd.	430,300	JP¥318.0m	0%	no data
4.46%	SBI Holdings Inc., Asset Management Arm	367,234	JP¥271.4m	-29%	0.1%
3.04%	Ueda Yagi Tanshi Co. Ltd., Asset Management Arm	250,000	JP¥184.8m	0%	0.22%
2.57%	Rakuten Investment Management, Inc.	211,800	JP¥156.5m	0%	0.08%
1.82%	Sanyo Chemical Industries,Ltd.	150,000	JP¥110.9m	0%	no data
1.82%	The Tokyo Tanshi Co., Ltd., Asset Management Arm	150,000	JP¥110.9m	0%	1.28%
1.41%	Yasunori Sasaki	116,200	JP¥85.9m	0%	no data
1.37%	GMO Click Securities, Inc., Asset Management Arm	113,000	JP¥83.5m	0%	0.73%
1.05%	au Kabucom Securities Co., Ltd., Asset Management Arm	86,392	JP¥63.8m	0%	0.26%
1.03%	Kenzo Iizuka	85,000	JP¥62.8m	0%	no data
0.99%	Japan Securities Finance Co. Ltd., Asset Management Arm	81,400	JP¥60.2m	0%	0.01%
0.84%	Masakazu Fukushima	69,000	JP¥51.0m	0%	no data
0.71%	Nomura Holdings Inc, Securities & Investment Arm	58,100	JP¥42.9m	-12.8%	no data
0.18%	Masaya Kimura	15,000	JP¥11.1m	0%	no data